Author :

Gabon 24

Published on:

21 July 2021

Add to your favorites :

0 comment(s) :

Join the conversation

Share :

Pfizer-BioNTech to manufacture Covid-19 vaccine in South Africa

Home > News > Coronavirus > Pfizer-BioNTech to manufacture Covid-19 vaccine in South Africa

Pfizer.Inc and BioNTech.SE will start producing Covi-19 vaccines in Africa next year, they announced on Wednesday. This comes through a collaboration with a South African human vaccine manufacturer BIOVAC. Ltd.

In a press release, Pfizer-BioNTech Covid-19 manufacturers announced the signing of a letter of intent with The Biovac Institute (Pty) Ltd, a Cape Town-based, South African bio-pharmaceutical company, to manufacture their vaccine for distribution within the African Union.

The move comes following the pharmaceutical companies’ determination to provide fair and equitable access of the Pfizer-BioNTech Covid-19 vaccine to everyone, everywhere including the African continent. 

“We aim to enable people on all continents to manufacture and distribute our vaccine while ensuring the quality of the manufacturing process and the doses,” Ugur Sahin, M.D., CEO and Co-founder of BioNTech said.

The news comes a few days after the continent reached 6 million Covid-19 cases, witnessing a third wave of contaminations. Unlike the increase in the number of infections, the vaccination rate on the continent remains low with just over 20 million full vaccine doses administered to a population of over 1.3 billion. 

The vaccination programme on the continent has been plagued by a shortage of doses, much of which are supplied by the global vaccine distribution initiative COVAX. Manufacturing doses on the continent may address the issue. 

“We believe this collaboration will create an opportunity to more broadly distribute vaccine doses to people in harder-to-reach communities, especially those on the African continent,” Dr. Morena Makhoana, CEO of Biovac stated. 

For Dr John Nkengasong, the Director of the African Centers for Disease Control and Prevention (Africa CDC) the announcement “is great and welcome news that must be celebrated in the context of this pandemic as every action counts. I see this as a part of the collective action to address technology transfer and intellectual property.”

Biovac’s annual production will exceed 100 million finished doses to be exclusively distributed in all the African Union countries.

Chat HQ

Start the conversation, not the fire. Courtesy is appreciated

Next Post
Notifier de
0 Commentaires
Inline Feedbacks
View all comments


Restez informés de notre actualité


Recent posts

Abdelaziz Bouteflika, Algeria’s Former President dies – Age 84

18 September 2021AfricaNewsTop news

Tech : Apple announces iPhone 13 Series – It is still pricey!

15 September 2021NewsTop newsWorld

Gabon: Creation of a High Commission of the Republic

15 September 2021GabonNewsTop news


Would love your thoughts, please comment.x